ISEDVI Trademark
Trademark Overview
On Thursday, July 14, 2022, a trademark application was filed for ISEDVI with the United States Patent and Trademark Office. The USPTO has given the ISEDVI trademark a serial number of 97503648. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, June 9, 2026. This trademark is owned by Eli Lilly and Company. The ISEDVI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascula...
General Information
| Serial Number | 97503648 |
| Word Mark | ISEDVI |
| Filing Date | Thursday, July 14, 2022 |
| Status | 734 - FIFTH EXTENSION - GRANTED |
| Status Date | Tuesday, June 9, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 6, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 4, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
Trademark Events
| Event Date | Event Description |
| Monday, July 18, 2022 | NEW APPLICATION ENTERED |
| Thursday, August 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 28, 2023 | ASSIGNED TO EXAMINER |
| Sunday, April 30, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 17, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 6, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 6, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 1, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, January 8, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, January 8, 2024 | SOU EXTENSION 1 FILED |
| Monday, January 8, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, January 10, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 12, 2024 | SOU EXTENSION 2 FILED |
| Friday, July 12, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, July 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 9, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 9, 2025 | SOU EXTENSION 3 FILED |
| Thursday, January 9, 2025 | SOU EXTENSION 3 GRANTED |
| Thursday, January 9, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 10, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 10, 2025 | SOU EXTENSION 4 FILED |
| Thursday, July 10, 2025 | SOU EXTENSION 4 GRANTED |
| Friday, July 11, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, January 16, 2026 | SOU TEAS EXTENSION RECEIVED |
| Monday, May 11, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, May 11, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, May 11, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, May 11, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, June 9, 2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Sunday, May 10, 2026 | SOU EXTENSION 5 FILED |
| Tuesday, June 9, 2026 | SOU EXTENSION 5 GRANTED |
| Wednesday, June 10, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
